4.1 Article

Impact of reimbursement restriction on drug market sales under the National Health Insurance in Japan

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Medicine, General & Internal

Medicare and the Shocking US Food and Drug Administration Approval of Aducanumab Crisis or Opportunity?

Francis J. Crosson et al.

JAMA INTERNAL MEDICINE (2021)

Article Pharmacology & Pharmacy

Assessing the Accuracy of Sales Forecasts Submitted by Pharmaceutical Companies Applying for Reimbursement in Austria

Michael Kossmeier et al.

Summary: In Austria, the majority of sales forecasts provided by pharmaceutical companies for reimbursement evaluations were highly inaccurate and overly optimistic, with a median overestimation of actual sales by 33%. This highlights the need for caution when using such forecasts for reimbursement procedures.

FRONTIERS IN PHARMACOLOGY (2021)

Review Economics

Health technology assessment in Japan: a work in progress

Isao Kamae et al.

JOURNAL OF MEDICAL ECONOMICS (2020)

Article Clinical Neurology

Preparing the health-care system to pay for new Alzheimer's drugs

Pei-Jung Lin et al.

ALZHEIMERS & DEMENTIA (2020)

Article Medicine, General & Internal

Drug Reimbursement Regulation in 6 Peer Countries

Ezekiel J. Emanuel et al.

JAMA INTERNAL MEDICINE (2020)

Article Medicine, General & Internal

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Susan Rogers Van Katwyk et al.

PLOS MEDICINE (2019)

Review Medicine, General & Internal

Health Care Spending in the United States and Other High-Income Countries

Irene Papanicolas et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Editorial Material Medicine, General & Internal

Value-Based Pricing for Drugs Theme and Variations

Anna Kaltenboeck et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

News Item Biotechnology & Applied Microbiology

Rollout of high-priced cell and gene therapies forces payer rethink

Melanie Senior

NATURE BIOTECHNOLOGY (2018)

Article Health Care Sciences & Services

The effect of essential medicines programme on rational use of medicines in China

Yanhong Gong et al.

HEALTH POLICY AND PLANNING (2016)

Review Medicine, General & Internal

The High Cost of Prescription Drugs in the United States Origins and Prospects for Reform

Aaron S. Kesselheim et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)